Analysis of the Literature on Chronic Cough in Children
Marcello Bergamini1, Ahmad Kantar2, *, Renato Cutrera3, Italian Pediatric Cough Interest Group4
Identifiers and Pagination:Year: 2017
First Page: 1
Last Page: 9
Publisher ID: TORMJ-11-1
Article History:Received Date: 27/01/2017
Revision Received Date: 06/03/2017
Acceptance Date: 06/03/2017
Electronic publication date: 27/04/2017
Collection year: 2017
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Throughout childhood, various developmental phenomena influence the cough reflex. Among these are the modifications in the anatomy and functions of the respiratory tract and the central and peripheral nervous systems. Moreover, after birth, the immunological response undergoes progressive transformations with the acquisition of immune memory processes. These conditions make infections and airway abnormalities the overwhelming cause of chronic cough in children and infants. In children, chronic cough should be treated on the basis of etiology. The aim of this article is to provide thorough research and analysis of the medical literature published up to 2014 on chronic cough in children as a disease entity, including the epidemiologic, etiologic, diagnostic, prognostic, and therapeutic aspects.
Our results demonstrate differences in the definition of chronic cough, the characteristics of diagnostic procedures, study settings, and prevalence of the main causes. However, few studies regarding epidemiology and the quality of life have been reported. Many therapeutic approaches that are considered effective in adults with chronic cough seem to be less efficient in children. Regardless of the setting, whether pediatric or non-pediatric, children with chronic cough should be carefully evaluated using child-specific protocols and algorithms. Awareness of the various pathophysiological conditions associated with chronic cough is vital for making a correct diagnosis and providing appropriate treatment. The prevalence of the different causes of chronic cough depends on various issues. Among these are the population under consideration and its age range, infectious disease control and prevention, the diagnostic procedures employed, disease definition criteria, and the local health system. Clinical guidelines for the management of children with chronic cough should take these components into consideration. Further clinical and basic research studies are still needed for better diagnosis, treatment, and prevention of chronic cough in children.
The cough reflex causes modifications of normal breathing patterns . This reflex is a complex and precisely timed neuromuscular phenomenon that involves the diaphragm, chest wall muscles, cervical muscles, abdominal muscles, laryngeal abductor and adductor muscles, and both medullary and cortical brain regions [2-4]. Throughout childhood, various developmental phenomena influence the cough reflex. Among these are modifications in the anatomy and functions of the respiratory airways and the central and peripheral nervous systems. Furthermore, because of the immature immunological response, infection is the main cause for cough in infancy. In general, children are more vulnerable to environmental factors. The impairment or absence of the cough reflex can be harmful and even fatal in some disease conditions. However, a cough may be the first symptom of many diseases or conditions affecting the respiratory tract, as a cough can represent more than a defense mechanism. Through its persistence, it becomes a helpful indicator of potential disease conditions for both patients and physicians. Almost all diseases of the respiratory tract, and in some cases of the extra-respiratory tract, can cause chronic cough. For the physician, it is most important to identify the serious disorders that require prompt management .
The aim of this article is to provide thorough research and analysis of the existing medical literature up to 2014 on chronic cough in children as a disease entity, including its epidemiologic, etiologic, diagnostic, prognostic, and therapeutic aspects. Given that chronic cough is not commonly considered a concrete pathological entity, but rather a persistent symptom of a chronic disease, reports in the literature addressing a single disorder causing chronic cough were not included in our present research.
The following sources were selected to identify the primary studies, secondary sources, and guideline searches:
- MedLine (through the PubMed search engine)
- Cochrane Database of Systematic Reviews (CDSR; The Cochrane Library)
- Database of Abstract of Reviews of Effects (DARE)
- The principal Guideline Banks (LG) on the website of Gruppo Italiano di Medicina Basata sulle Evidenze (GIMBE) .
From the keyword registers in Embase (Emtree) and PubMed (MeSH database), we employed the following terms for data collection: ‘cough’, ‘coughing’, and ‘chronic’, matched case-by-case in separate search strings to the keywords ‘epidemiology’, ‘prevalence’, ‘incidence’, ‘etiology’, ‘diagnosis’, ‘prognosis’, and ‘therapy’. In PubMed, we used the pre-defined phrase ‘chronic cough children’ and the search tool for specific clinical areas known as clinical queries.
With these, it was possible to separately explore the fields of etiology, diagnosis, prognosis and therapy, as well as any ‘clinical prediction guides’ that were available. Our literature search was conducted without time limits and was concluded on September 8, 2014. The selection was further restricted to reports written in English or Italian and involving humans within the age range of 0 to 18 years. For articles regarding therapy, we limited our search to randomized controlled trials (RCTs). In our investigation, we excluded non-systematic reviews, editorials, letters, works of pure research, and grey literature.
RESULTS AND DISCUSSION
There are limited data reporting the prevalence of chronic cough in children. ln a study conducted in 2002 on a population of 2275 children aged 1-15 years living in rural areas of India, chronic recurrent cough was present in 1.06% of cases . Whereas in a study conducted in China in 2010 on children living in six different urban areas, a 21-28% increase in chronic cough was observed for each interquartile increase in the concentration of atmospheric pollutants, such as total suspended particles, nitrogen dioxide, and sulphur dioxide .
Data from an Australian prevalence study  that was conducted on a cohort of children enlisted following urgent admittance to a tertiary center for acute respiratory disease reported that 20% of the children (aged 1-14 years old) had chronic cough (cough for more than 4 weeks). However, this percentage represents the prevalence in a selected population that was admitted to a tertiary center following acute respiratory illness, which is quite different from that in the general population.
More pertinent to Italian settings was the SIDRIA-2 observational study  that was conducted on 33,000 children and adolescents in various parts of the country. This study showed a significant increase in cough and chronic catarrh with an increase in prevalence from 2.2% in traffic-free areas to 3.2% in areas with intense traffic. Moreover, this study demonstrated differences between areas with rare truck passage (prevalence 2.0%) and areas with frequent (2.9%) or continuous (3.9%) truck passage. The increase in the prevalence of chronic cough associated with low automobile traffic was not significant.
Bibliographic research in terms of EBM revealed only one strictly diagnostic publication, which was an Australian study conducted in 2006 . The prospective cohort study included 100 children with an average age of 2.8 years who coughed significantly and persistently for more than 3 weeks. Although the trial’s overall methodological quality was good, it is worth keeping in mind that these children had a median cough duration of 6 months, suggesting a possible high level of disease severity.
The authors identified wet cough as a good indicator of a specific cough (a cough with a specific cause), which was the primary aim of the study. In reality, however, with a positive likelihood ratio (LR+) barely above 1 (1.29), this parameter seems to provide an irrelevant diagnostic performance in both populations. As expected, better positive predictability was provided by hemoptysis and chronic dyspnea. In addition, the study revealed diagnostic tools with a positive predictability for a specific etiology, which included the following: objective chest examination with an LR+ of 2.4, radiography anomalies with an LR+ of 2.92, and spirometry with an LR+ of 2.33. This latter examination was performed in only 32 children who were older than 6 years of age. Wet cough was shown to be the lone parameter that was effective mainly in excluding a specific cause in a low-prevalence population (LR- of 0.15). However, factors including history (mainly pointers), clinical evaluation, and diagnostic tools each had an LR- >0.3, thus, demonstrating the scarcity of the efficacy in an exclusion diagnosis.
Based on these results, the authors subsequently recommended in their guidelines chest radiography and spirometry as diagnostic tools that should be used in children who have experienced cough for longer than 4 weeks.
A recent systematic review  determined that only the pediatric cough quality of life (PC-QoL) questionnaire can be considered a valid means for assessing the severity and impact of a cough on a child’s health and that evidence on the validity of cough diaries or visual analogue scale scores is currently insufficient. Four relevant publications were obtained using PubMed clinical queries. Two of these publications focused on the validation of the PC-QoL [13, 14], one was dedicated to the validation of a questionnaire on the quality of the cough , and the remaining publication regarded the validation of a constructed questionnaire on cough hypersensitivity syndrome  that was not pertinent to the scope of this review.
Etiology and Algorithms for Management of Chronic Cough
The earliest publication we found in this field was a systematic review (SR) on the causal relationship between parental smoking and various respiratory symptoms in children, including cough . The review, which included 34 studies, demonstrated that the odds ratio (OR) for exposure to parental smoking and cough was 1.40 (95% confidence interval [CI] 1.27-1.53). The authors concluded that the relationship between parental smoking and respiratory symptoms “seems very likely” to be causal given the statistical significance, robustness to adjustment for confounding factors, consistency of the findings in different countries, and evidence of dose response.
In the above-cited observational study that was conducted in a rural Indian population of 2275 children, Singh et al. reported bronchial asthma as the most common cause of chronic cough in 66.7% of the studied group, followed by post-nasal drip in 25%. A family history of smoking was recognized in 16.7% of cases, which is in contrast to 6.4% in the control group (p=0.05). There was no significant association with overcrowding, presence of pets, or the category of fuel employed for home cooking. However, this study cannot be compared to case studies in Western nations because of the large differences in health services, hygiene, and socioeconomic conditions.
The second study by the Italian SIDRIA-2 Group was conducted in 2005 and focused on indoor exposure and respiratory and allergic disorders . The study revealed that pollution was a significant causal link between chronic cough, exposure to domestic molds, and the presence of dogs during the first year of life (OR 1.89; 95%CI 1.31-2.71 and OR 1.87; 95%CI 1.12-3.11, respectively). Indoor exposure to dogs in the first year of life apparently mantains its effects even throughout adolescence (OR 2.03; 95%CI 1.12-3.67). The last four publications found during our research were conducted in different international settings and with more rigorous bases. The earliest of these was a study performed by an Australian group over a 2-year period. In that study, 108 children with an average age of 2.8 years and chronic cough were subjected to a standardized sequence of a diagnostic pathway approach in which chest radiography and spirometry were primarily performed when possible. Bronchoscopic investigation, computed tomography scanning, and oesophageal pH-metric monitoring were included in the second phase of the pathway .
The second report is a Turkish study published in 2008 that was conducted on 108 children with an average age of 8.5 years that applied the recommendations encompassed in the guidelines of the American College of Chest Physicians (ACCP) [20, 21]. In that study, children with specific cough alarm indicators (pointers) were excluded from the algorithm at the beginning. In a third prospective study carried out in the USA that lasted 4 years, a fairly small number of children (n=40) with an average age of 7.8 years and persistent cough for more than 8 weeks were subjected to a rather intensive and detailed work-up that is typical of a third-level center . The fourth publication involved a larger cohort than those in the previous three studies. It included 346 children from six Australian centers (five centers were located in cities, and one center was located in a rural area) . Moreover, children were separated into four age groups (0-2, 2-6, 6-12, and >12 years) and were managed in accordance with a pathway similar to the one utilized by the Turkish authors that followed the ACCP guidelines in which chest radiography and spirometry were conducted during an early phase. In the absence of specific pointers, the children underwent a diagnostic-therapeutic trial with inhaled corticosteroids when the chronic cough was dry/unproductive or with antibiotics when the cough was wet/productive.
As can be observed in a summary of these studies in Table 1, large differences are evident, including differences in the definition of the chronic cough duration (4 versus 8 weeks), age groups, number of subjects, and duration of the cough prior to enrolment (16 weeks in the studies by Asilsoy and Chang, 18 weeks in the study by Khoshoo, and 6 months in the study by Marchant). Moreover, the study by Khoshoo differs from the other 3 studies by the lack of an a priori definition of the ascribed etiology and how much change was considered to be important. Differences were observed in the-characteristics of the adopted diagnostic procedures, the settings in which the studies were conducted, the initial inclusion or exclusion criteria (children presenting alarm signals indicating a cough with specific etiology were excluded in Asilsoy’s study) and in the methodological quality of statistical analyses.
|PBB||Asthma||UACS||GER||Bronchiectasis||Tracheo-malacia||Habitual-psychogenic cough||Spontaneous resolution||Other|
|Marchant 2006  (2.6 yrs average age)||40%||4%||3%||3%||6%||-||1%||22%||21%|
2008  (8.4 yrs average age)
Khoshoo 2009 
(7.8 yrs average age)
2012  (4.5 yrs average age)
The four above-mentioned studies present noteworthy differences in the frequencies of various etiologic diagnoses, which were highest for asthma, gastroesophageal reflux (GER), and upper airway disorders (post-nasal drip) in the older populations (Khoshoo and Asilsoy studies). In the younger populations studied, the diagnosis with the highest frequency was protracted bacterial bronchitis. The significance of this latter correlation was demonstrated in the Australian multi-center study in which protracted bacterial bronchitis was observed in approximately 54% of children less than 2 years old (n=124), in 40% of children aged between 2 and 4 years (n=126), in 27% of children aged between 6 and 12 years (n=82), and in 29% of those older than 12 years (n=14). No differences or trends were evident in the frequencies of the other four most often-reported diagnoses. However, a significantly higher frequency of tracheomalacia was observed in the aborigine population than in the white population (29.4% vs. 6.7%; p=0.001).
To assess the validity of management according to the standardized clinical management, we examined a single recent Australian trial study [24, 25]. That study is the only study dedicated to the use of algorithms subsequent to the 2009 Cochrane SR that failed to identify any pertinent RCT . The multi-center study used a pragmatic design to test whether management of chronic cough in children in accordance with an evidence-based pathway was feasible, reliable, and improved clinical outcomes. The principal objective was to test the efficacy of the pathway. Because an RCT comparing use versus non-use of the pathway was not possible, the authors designed their study to evaluate delayed versus early employment of the pathway. Approximately 75% of the group of children enrolled in an Australian trial  had previously been members of a population examined in a randomized study [24, 25]. The intervention consisted of the use of a diagnostic-therapeutic algorithm at different timings: 2-3 weeks after the request for admission (early-arm) or 5-7 weeks after the request for admission (delayed-arm). One hundred and forty children with an average age of 4.6 years were randomly selected to undergo intervention within 2-3 weeks, whereas 132 received the intervention within 5-7 weeks, which represented the standard caregiving time at the various centers that were involved in the study. The aim of the study was to demonstrate, with an 82% power and a 5% significance level, the statistical significance of a difference of at least 20% in the “resolution of the cough” within 6 weeks of acceptance for admission (this parameter constituted one of the two primary outcomes of the randomized controlled trial). The other primary outcome was the difference in the parent-proxy cough-specific quality of life (PC-QoL) completed within 6 weeks of acceptance for admission. At the end of the study, the intention-to-treat analysis demonstrated a statistically significant difference for the resolution of the cough within 6 weeks (54.3% vs. 29.5%; p=0.01; number needed to treat [NNT]=4). The authors also affirmed that a significant improvement in PC-QoL was observed in both groups and was greater in the early treated group (the p-value was not specified). That study, in which blindness was obviously not applicable, had good methodological quality in terms of other risks of potential bias. The period of the cough duration in randomized patients was fairly long (4 months), which must be noted particularly in comparison with the Italian children, for whom access to pediatric care is easier, thus, allowing earlier initiation of treatment.
Chronic Cough Treatment
An examination of the secondary sources not included in the Cochrane Collaboration revealed a review lacking the minimum systematic criteria that we decided not to include  and an SR that was conducted in 2013  in which childhood studies constituted only a scarcely relevant part of the overall study. The CDSR instead presents an “umbrella review” composed of up to 15 SRs that are continuously updated on the website, which provides an important, complete, and methodologically irreprehensible body of evidence. However, it currently lacks wide clinical significance because of the general scarcity of well-structured studies on pharmacological and non-pharmacological therapies for chronic cough in children. One of these 15 SRs examined the management algorithms that were mentioned earlier in this review . Five SRs [29-33] did not include any pertinent work, nor did our research reveal more recent pertinent trials. These include trials with chromones, anticholinergic agents, obstructive sleep apnea syndrome therapies, modification of indoor environments, and honey or cough drop usage. Regarding β-2 agonists, no efficacy was demonstrated by the only RCT study that was included in a dedicated SR . The same applies to the two trials included in an SR examining the use of leukotriene receptor antagonists . In an SR examining the use of methylxanthine, some cohort studies appeared to have demonstrated an efficacy of dubious clinical relevance on the symptoms of chronic cough despite the well-known undesired side-effects of the drug . An SR on the use of antibiotics in a chronic cough post-bronchiolitis indicated only one RCT in which the efficacy of clarithromycin was not significant .
An SR on antihistamines included three therapeutic studies with conflicting results. The data from the two larger therapeutic studies that described no beneficial effect are in contrast to a smaller study that demonstrated that the second-generation antihistamine cetirizine was beneficial in reducing coughs associated with seasonal allergic rhinitis .
In regard to these latter Cochrane SR references [29-33], our research failed to discover any subsequent noteworthy trials. There are two SRs regarding the use of inhaled corticosteroids [39, 40]. Among the various selected works, only one trial (which contained serious methodological defects) demonstrated a relatively modest efficacy of fluticasone dipropionate for nocturnal cough . The drug was administered at a high dosage of 2 mg/day for 3 days, then 500 μg/day for the following 11 days. None of the dietetic or pharmacological treatments studied in the six RCTs of an SR examining the treatment of GER were shown to be effective . However, it is also worth noting that in the work conducted with proton pump inhibitors, only 1 patient of the 11 that were treated experienced an undesired side effect (number needed to harm = 11) . Only one work was published after the SR on GER by Chang et al.; this work was a Chinese RCT conducted on 19 children assigned to four groups in which the omeprazole-bethanecol combination appeared to reduce daytime coughing in children with GER .
The SR on the use of antibiotic therapy  instead selected only two randomized trials of modest quality: one conducted with erythromycin and the other with an under-dose of amoxicillin clavulanate. In the authors’ opinion, on the basis of only these two studies, it would be necessary to treat three children (NNT=3) with an antibiotic in order to obtain a significant improvement in persistent cough. These conclusions were conditioned by the methodological weakness of the study. One particularly relevant study was published after the final update of the latter SR, which was an RCT conducted in Australia in which 50 children with an average age of 1.9 years and with wet cough lasting for more than 3 weeks were randomized to 2 weeks of twice daily oral amoxicillin clavulanate (22.5 mg/kg/dose) or placebo . In this selected population, which was treated with low antibiotic doses (higher doses are commonly used in Italy), the NNT was only three children (95%CI 1.8-13.9).
We consider that there are four main international guidelines (American, British, Belgian, and Australian) on chronic cough in children that are most relevant [21, 47-49], all of which are important documents because they were produced by research groups of cough experts. Most of these groups have studied the phenomenon in great detail over the past two decades. Although numerous articles published in recent years have modified our knowledge of the etiology and management (algorithms and therapy) of chronic cough, until now (September 2014), none of the guidelines have been updated or revised. Moreover, the qualitative analysis of the three fundamental characteristics according to which guidelines should be produced (multidisciplinarity, systematic literature searches, and recommendation grading) leads to appraisals that often cannot be judged positively.
The ACCP guidelines were published in 2006; this version was not multidisciplinary (only physicians were involved), and the bibliographic assessment of the methodological criteria is not easy to consult .
The Belgian guidelines are not multidisciplinary, and they employed a non-conventional method of recommendations . The British guidelines lack multidisciplinarity, and bibliographic research was performed by the first author alone and was restricted to articles in English .
The Australian guidelines are the most recently updated guidelines . The authors state their recommendations according to the GRADE approach. Nonetheless, the authors referred to an inaccessible online document for details regarding the methodology. In addition to this, the authors declare that the research source was limited to PubMed. Only the British Thoracic Society guidelines offer a clear correlation between single recommendations and the sources of evidence supporting them. Although all these guidelines contain practical flow-charts for a diagnostic and/or therapeutic approach for children with chronic cough, they all had a restricted panel of reviewers. Moreover, the limited number of studies and investigations in this field has the potential to introduce bias. An updated cough guideline and an expert panel is expected to be published in the coming months by an international group .
Chronic cough is common in the pediatric population, yet the true prevalence of this condition remains difficult to define. Before receiving appropriate management, many children with chronic cough and their families continue to experience unnecessary or recurring medical consultation with a great impact on their quality of life. Physiologically, there are similarities and also significant differences between adults and children [51, 52]. As expected, the etiologies and management of cough in children differ from those used for adults. A chronic cough in a child should be treated on the basis of etiology; no evidence supports the use of medication for symptomatic cough relief. The benefits to the child of making an accurate diagnosis and prescribing adequate treatment, therefore, extends well beyond merely eliminating the cough.
Regardless of the setting, whether pediatric or non-pediatric, children with chronic cough should be carefully evaluated using child-specific protocols and algorithms. Those based on good evidence are more likely to improve the clinical outcomes. Knowledge of the pathophysiology of the different conditions that cause chronic cough is essential for disease management. Distinguishing the different phenotypes is helpful in achieving the correct diagnosis. There is a continuing search for the distinctive phenotypes of chronic cough patients who will prove responsive to one treatment rather than another . The prevalence of each etiology in a medical setting depends on various issues. Among these are the population under consideration and the variety in the ages of its constituents (infants, preschool, school-children), infectious disease control and prevention, diagnostic procedures employed, disease definition criteria, and the health system. Clinical algorithms for the management of children with chronic cough should consider these factors. Despite the apparently high prevalence of cough in children, the topic has been poorly researched. Further clinical and basic research studies are still needed for better diagnosis, treatment, and prevention of chronic cough in children.
CONFLICT OF INTEREST
The authors confirm that this article content has no conflict of interest.
|||Widdicombe JG. Afferent receptors in the airways and cough. Respir Physiol 1998; 114(1): 5-15.
|||Brooks SM. Perspective on the human cough reflex. Cough 2011; 7: 10.
|||Poliacek I, Stránsky A, Szereda-Przestaszewska M, et al. Cough and laryngeal muscle discharges in brainstem lesioned anaesthetized cats. Physiol Res 2005; 54(6): 645-54.
|||Morris KF, Baekey DM, Nuding SC, Dick TE, Shannon R, Lindsey BG. Invited review: Neural network plasticity in respiratory control. J Appl Physiol 2003; 94(3): 1242-52.
|||Chang AB. Causes, assessment and measurement of cough in children. In: Chung KF, Widdicombe JG, Boushey HA, Eds. Cough: causes, mechanisms and therapy. Oxford, UK: Blackwell Publishing Ltd. 2003; pp. 57-73.
|||Italian Group on Evidence-Based Medicine-GIMBE Available at: http://www.gimbe.org/ebp/getting.html|
|||Singh D, Arora V, Sobti PC. Chronic/recurrent cough in rural children in Ludhiana, Punjab. Indian Pediatr 2002; 39(1): 23-9.
|||Pan G, Zhang S, Feng Y, et al. Air pollution and childrens respiratory symptoms in six cities of Northern China. Respir Med 2010; 104(12): 1903-11.
|||Drescher BJ, Chang AB, Phillips N, et al. Chronic cough following acute respiratory illness in children. Respirology 2013; 18: 76.
|||Galassi C, Forastiere F, Biggeri A, et al. [SIDRIA second phase: objectives, study design and methods]. Epidemiol Prev 2005; 29(2)(Suppl.): 9-13.
|||Marchant JM, Masters IB, Taylor SM, Chang AB. Utility of signs and symptoms of chronic cough in predicting specific cause in children. Thorax 2006; 61(8): 694-8.
|||Schmit KM, Coeytaux RR, Goode AP, et al. Evaluating cough assessment tools: a systematic review. Chest 2013; 144(6): 1819-26.
|||Newcombe PA, Sheffield JK, Juniper EF, Petsky HL, Willis C, Chang AB. Validation of a parent-proxy quality of life questionnaire for paediatric chronic cough (PC-QOL). Thorax 2010; 65(9): 819-23.
|||Newcombe PA, Sheffield JK, Chang AB. Parent cough-specific quality of life: development and validation of a short form. J Allergy Clin Immunol 2013; 131(4): 1069-74.
|||Hartnick CJ, Zurakowski D, Haver K. Validation of a pediatric cough questionnaire. Ear Nose Throat J 2009; 88(11): 1213-7.
|||Morice AH, Faruqi S, Wright CE, Thompson R, Bland JM. Cough hypersensitivity syndrome: a distinct clinical entity. Lung 2011; 189(1): 73-9.
|||Cook DG, Strachan DP. Health effects of passive smoking. 3. Parental smoking and prevalence of respiratory symptoms and asthma in school age children. Thorax 1997; 52(12): 1081-94.
|||Simoni M, Lombardi E, Berti G, et al. [Effects of indoor exposures on respiratory and allergic disorders]. Epidemiol Prev 2005; 29(2)(Suppl.): 57-61.
|||Marchant JM, Masters IB, Taylor SM, Cox NC, Seymour GJ, Chang AB. Evaluation and outcome of young children with chronic cough. Chest 2006; 129(5): 1132-41.
|||Asilsoy S, Bayram E, Agin H, et al. Evaluation of chronic cough in children. Chest 2008; 134(6): 1122-8.
|||Chang AB, Glomb WB. Guidelines for evaluating chronic cough in pediatrics: ACCP evidence-based clinical practice guidelines. Chest 2006; 129(1 Suppl): 260S-83S.
|||Khoshoo V, Edell D, Mohnot S, Haydel R Jr, Saturno E, Kobernick A. Associated factors in children with chronic cough. Chest 2009; 136(3): 811-5.
|||Chang AB, Robertson CF, Van Asperen PP, et al. A multicenter study on chronic cough in children: burden and etiologies based on a standardized management pathway. Chest 2012; 142(4): 943-50.
|||Chang AB, Robertson CF, van Asperen PP, et al. Can a management pathway for chronic cough in children improve clinical outcomes: protocol for a multicentre evaluation. Trials 2010; 11: 103.
|||Chang AB, Robertson CF, van Asperen PP, et al. A cough algorithm for chronic cough in children: a multicenter, randomized controlled
study. Pediatrics 2013; 131(5): e1576-83.
|||Bailey EJ, Morris PS, Kruske SG, Chang AB. Clinical pathways for chronic cough in children. Cochrane Database Syst Rev 2008; 2(2): CD006595.
|||Gupta A, McKean M, Chang AB. Management of chronic non-specific cough in childhood: an evidence-based review. Arch Dis Child Educ Pract Ed 2007; 92(2): 33-9.
|||Yancy WS Jr, McCrory DC, Coeytaux RR, et al. Efficacy and tolerability of treatments for chronic cough: a systematic review and meta-analysis. Chest 2013; 144(6): 1827-38.
|||Chang AB, McKean M, Morris P. Inhaled anti-cholinergics for prolonged non-specific cough in children. Cochrane Database Syst Rev 2004; 1(1): CD004358.
|||Chang A, Marchant JM, McKean M, Morris P. Inhaled cromones for prolonged non-specific cough in children. Cochrane Database Syst Rev 2004; 2(2): CD004436.
|||Teoh L, Hurwitz M, Acworth JP, van Asperen P, Chang AB. Treatment of obstructive sleep apnoea for chronic cough in children. Cochrane Database Syst Rev 2011; 4(4): CD008182.
|||Donnelly D, Everard MM, Chang AB. Indoor air modification interventions for prolonged non-specific cough in children. Cochrane Database Syst Rev 2006; 3(3): CD005075.
|||Mulholland S, Chang AB. Honey and lozenges for children with non-specific cough. Cochrane Database Syst Rev 2009; 2(2): CD007523.
|||Tomerak AA, Vyas H, Lakenpaul M, McGlashan JJ, McKean M. Inhaled beta2-agonists for treating non-specific chronic cough in children. Cochrane Database Syst Rev 2005; 3(3): CD005373.
|||Chang AB, Winter D, Acworth JP. Leukotriene receptor antagonist for prolonged non-specific cough in children. Cochrane Database Syst Rev 2006; 2(2): CD005602.
|||Chang AB, Halstead RA, Petsky HL. Methylxanthines for prolonged non-specific cough in children. Cochrane Database Syst Rev 2005; 3(3): CD005310.
|||McCallum GB, Morris PS, Chang AB. Antibiotics for persistent cough or wheeze following acute bronchiolitis in children. Cochrane Database Syst Rev 2012; 12: CD009834.
|||Chang AB, Peake J, McElrea MS. Anti-histamines for prolonged non-specific cough in children. Cochrane Database Syst Rev 2008; 2(2): CD005604.
|||Tomerak AA, McGlashan JJ, Vyas HH, McKean MC. Inhaled corticosteroids for non-specific chronic cough in children. Cochrane Database Syst Rev 2005; 4(4): CD004231.
|||Anderson-James S, Marchant JM, Acworth JP, Turner C, Chang AB. Inhaled corticosteroids for subacute cough in children. Cochrane Database Syst Rev 2013; 2(2): CD008888.
|||Davies MJ, Fuller P, Picciotto A, McKenzie SA. Persistent nocturnal cough: randomised controlled trial of high dose inhaled corticosteroid. Arch Dis Child 1999; 81(1): 38-44.
|||Chang AB, Lasserson TJ, Gaffney J, Connor FL, Garske LA. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev 2011; 1(1): CD004823.
|||Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr 2009; 154(4): 514-520.e4.
|||Adamko DJ, Majaesic CM, Skappak C, Jones AB. A pilot trial on the treatment of gastroesophageal reflux-related cough in infants. Zhongguo Dang Dai Er Ke Za Zhi 2012; 14(5): 321-7.
|||Marchant JM, Morris P, Gaffney JT, Chang AB. Antibiotics for prolonged moist cough in children. Cochrane Database Syst Rev 2005; 4(4): CD004822.
|||Marchant J, Masters IB, Champion A, Petsky H, Chang AB. Randomised controlled trial of amoxycillin clavulanate in children with chronic wet cough. Thorax 2012; 67(8): 689-93.
|||Leconte S, Paulus D, Degryse J. Prolonged cough in children: a summary of the Belgian primary care clinical guideline. Prim Care Respir J 2008; 17(4): 206-11.
|||Shields MD, Bush A, Everard ML, McKenzie S, Primhak R. BTS guidelines: Recommendations for the assessment and management of cough in children. Thorax 2008; 63(Suppl. 3): iii1-iii15.
|||Gibson PG, Chang AB, Glasgow NJ, et al. CICADA: Cough in Children and Adults: Diagnosis and Assessment. Australian cough guidelines summary statement. Med J Aust 2010; 192(5): 265-71.
|||Irwin RS, French CT, Lewis SZ, Diekemper RL, Gold PM. Overview of the management of cough. Chest 2014; 146(4): 885-9.
|||Chang AB. Pediatric cough: children are not miniature adults. Lung 2010; 188(Suppl. 1): S33-40.
|||Kantar A, Bernardini R, Paravati F, Minasi D, Sacco O. Chronic cough in preschool children. Early Hum Dev 2013; 89(Suppl. 3): S19-24.